Hemangioendothelioma

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Hemangioendothelioma
Classification and external resources
ICD-O: 9130-9133

WikiDoc Resources for

Hemangioendothelioma

Articles

Most recent articles on Hemangioendothelioma

Most cited articles on Hemangioendothelioma

Review articles on Hemangioendothelioma

Articles on Hemangioendothelioma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemangioendothelioma

Images of Hemangioendothelioma

Photos of Hemangioendothelioma

Podcasts & MP3s on Hemangioendothelioma

Videos on Hemangioendothelioma

Evidence Based Medicine

Cochrane Collaboration on Hemangioendothelioma

Bandolier on Hemangioendothelioma

TRIP on Hemangioendothelioma

Clinical Trials

Ongoing Trials on Hemangioendothelioma at Clinical Trials.gov

Trial results on Hemangioendothelioma

Clinical Trials on Hemangioendothelioma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemangioendothelioma

NICE Guidance on Hemangioendothelioma

NHS PRODIGY Guidance

FDA on Hemangioendothelioma

CDC on Hemangioendothelioma

Books

Books on Hemangioendothelioma

News

Hemangioendothelioma in the news

Be alerted to news on Hemangioendothelioma

News trends on Hemangioendothelioma

Commentary

Blogs on Hemangioendothelioma

Definitions

Definitions of Hemangioendothelioma

Patient Resources / Community

Patient resources on Hemangioendothelioma

Discussion groups on Hemangioendothelioma

Patient Handouts on Hemangioendothelioma

Directions to Hospitals Treating Hemangioendothelioma

Risk calculators and risk factors for Hemangioendothelioma

Healthcare Provider Resources

Symptoms of Hemangioendothelioma

Causes & Risk Factors for Hemangioendothelioma

Diagnostic studies for Hemangioendothelioma

Treatment of Hemangioendothelioma

Continuing Medical Education (CME)

CME Programs on Hemangioendothelioma

International

Hemangioendothelioma en Espanol

Hemangioendothelioma en Francais

Businness

Hemangioendothelioma in the Marketplace

Patents on Hemangioendothelioma

Experimental / Informatics

List of terms related to Hemangioendothelioma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hemangioendothelioma is used to describe a group of vascular neoplasms that may be considered benign or malignant in their activity. They have been described as masses that fall between a hemangioma and angiosarcoma. They are vascular tumors that commonly present with an enlarging mass and have been reported in the head and neck, intestines, lungs, lymph nodes, pleura, retroperitoneum, stomach, and many other body sites. Surgical resection, radiotherapy, and chemotherapy have all been used to treat these masses.

In hemangioendotheliomas, the cell of origin is the endothelial cell, and they range from benign to frankly malignant lesions.

They typically occur in young patients, especially in the soft tissues of the limbs and are often closely related to veins, from which they are thought to arise. Less frequently they can arise in bone (osseous haemangioendothelioma), in which case they are most often seen in the calvaria, spine or lower limbs.

Types of Hemangioendotheliomas

Diagnosis

Radiologically they appear the same as angiosarcomas and haemangiopericytomas.

X-rays

Nonspecific soft tissue mass. When involving bone, they are predominatly lytic, and may mimic haemangiomas with a course honeycomb appearance.

Angiography

Dense, well-circumscribed areas of enhancement with early draining veins and shunting. Hemangiopericytoma are described as having a pedicle formed by the arteries supplying the tumor from which vessels branch to encircle the tumor.

CT

Non specific soft tissue mass, with density similar to muscle but demonstrating bright contrast enhancement. CTA may demonstrate large feeding vessels.

MRI

Brightly enhancing soft tissue mass, often hyperintense on T2WI, with prominant flow voids, most marked in hemangiopericytomas.

References

  • Murphy M. et al "Musculoskeletal Angiomatous Lesions" RadioGraphics: July 1, 1995 -- Volume 15, Number 4

External links


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools